- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
Congressional members Barney Frank (D-MA) and Jared Polis (D-CO) wrote to U.S. Attorney General Eric Holder earlier this week urging him to re-avow his commitment to an October 2009 memorandum that de-emphasized federal enforcement regarding medical marijuana.
The 2009 memo was drafted by then-Deputy Attorney General David Ogden and sent to all of the U.S. Attorneys in medical marijuana states. Since then, some of those same U.S. Attorneys have sent letters to local and state officials in at least 10 states, threatening some of them with criminal prosecution if they implement licensed production and distribution systems.
According to The Hill, Frank and Polis in their June 20th letter pointed to the stark divide between federal policy and practice:
Recent actions by United States Attorneys across the country have prompted states to deny patients safe and reliable access to their medicine.
Further emphasizing this point, U.S. Attorney Melinda Haag sent a letter to Oakland, California City Attorney John Russo in February stating that the Justice Department:
will enforce the [Controlled Substances Act] vigorously against individuals and organizations that participate in unlawful manufacturing and distribution activity involving marijuana, even if such activities are permitted under state law.
Letters sent to lawmakers in the States of Arizona, California, Hawaii, Montana, Rhode Island, and Washington have killed, derailed or suspended the implementation of local medical marijuana laws. Frank and Polis responded to this intimidation by explaining how obstructing medical marijuana laws needlessly expends precious federal resources and “harms the people whose major goal is to seek relief from pain wholly caused by illness.”
There are now hundreds of thousands of medical marijuana patients in states where the medication is legal. These patients will either purchase medical marijuana safely at state-regulated entities or seek it through unregulated channels in the criminal market.
Any day now, Holder is expected to announce a “clarification” to the Ogden memo. Patients and supporters are encouraged to contact his office and let Holder know that the federal government should let local and state governments implement their own medical marijuana laws and to focus on developing a federal policy that recognizes marijuana’s medical efficacy. Anything less would be a disservice to our most vulnerable.